CLASS II ONGOING Device recall · Reported 1 Sep 2021 · FDA Enforcement Report

Accu-Chek SmartView Test Strip, Blood Glucose Monitoring System recalled

Roche Diabetes Care is recalling Accu-Chek SmartView Test Strip, Blood Glucose Monitoring System, distributed nationwide in the US. The recall was initiated on 28 Jul 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSince this is a labeling correction, this recall is not lot specific and is applicable to all non-expired lots.
Quantity recalled1,150,755 (US)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2353-2021
FDA event ID
88362
Recalling firm
Roche Diabetes Care, Indianapolis, IN
Classification
Class II
Status
Ongoing
Recall initiated
28 Jul 2021
FDA classified
26 Aug 2021
Reported
1 Sep 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Labeling Errors

Timeline

28 Jul 2021Recall initiated by company
26 Aug 2021Classified by FDA+29 days
1 Sep 2021Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Test strip vials may open while inside sealed cartons during shipment. An open vial might expose the test strips to humidity, which might damage the strips and result in inaccurate results, potentially leading to inappropriate therapy decisions and adverse health consequences.

Product as listed by the FDA

Accu-Chek SmartView Test Strip, Blood Glucose Monitoring System, Model numbers: 06337538001, 06337546001, 06337562001

Where it was distributed

Worldwide distribution - US Nationwide distribution.

Nationwide

Questions about this recall

Is Accu-Chek SmartView Test Strip, Blood Glucose Monitoring System recalled?

Yes. Roche Diabetes Care recalled Accu-Chek SmartView Test Strip, Blood Glucose Monitoring System on 28 Jul 2021. The recall is Class II and its status is Ongoing. Recall number Z-2353-2021.

Why was it recalled?

Test strip vials may open while inside sealed cartons during shipment. An open vial might expose the test strips to humidity, which might damage the strips and result in inaccurate results, potentially leading to inappropriate therapy decisions and adverse health consequences.

Which lots are affected?

Since this is a labeling correction, this recall is not lot specific and is applicable to all non-expired lots.

Where was it sold?

Worldwide distribution - US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diabetes Care

All 29

Other Insulin Pumps & Glucose Monitors recalls

All 459